Interstitial cystitis (bladder pain syndrome)

References

Key articles

Hanno PM, Erickson D, MOldwin R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015 May;193(5):1545-53.Full text  Abstract

Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol. 2007 Feb;177(2):450-6. Abstract

European Association of Urology. Chronic pelvic pain. 2018 [internet publication].Full text

van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008 Jan;53(1):60-7. Abstract

Porru D, Tinelli C, Gerardini M, et al. Evaluation of urinary and general symptoms and correlation with other clinical parameters in interstitial cystitis patients. Neurourol Urodyn. 2005;24(1):69-73. Abstract

Erickson DR, Tomaszewski JE, Kunselman AR, et al. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005 Jan;173(1):93-7. Abstract

Alagiri M, Chottiner S, Ratner V, et al. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology. 1997 May;49(5A Suppl):52-7. Abstract

Reference articles

1. Hanno PM, Erickson D, MOldwin R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015 May;193(5):1545-53.Full text  Abstract

2. Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol. 2007 Feb;177(2):450-6. Abstract

3. European Association of Urology. Chronic pelvic pain. 2018 [internet publication].Full text

4. van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008 Jan;53(1):60-7. Abstract

5. Han E, Nguyen L, Sirls L, et al. Current best practice management of interstitial cystitis/bladder pain syndrome. Ther Adv Urol. 2018 Mar 19;10(7):197-211.Full text  Abstract

6. Hanno P, Lin A, Nordling J, et al; Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Bladder pain syndrome international consultation on incontinence. Neurourol Urodyn. 2008 Jan;53(1):60-7.Full text  Abstract

7. Porru D, Tinelli C, Gerardini M, et al. Evaluation of urinary and general symptoms and correlation with other clinical parameters in interstitial cystitis patients. Neurourol Urodyn. 2005;24(1):69-73. Abstract

8. Curhan GC, Speizer FE, Hunter DJ, et al. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999 Feb;161(2):549-52. Abstract

9. Sant GR, Hanno PM. Interstitial cystitis: current issues and controversies in diagnosis. Urology. 2001 Jun;57(6 Suppl 1):82-8. Abstract

10. Clemens JQ, Meenan RT, Rosetti MC, et al. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005 Jan;173(1):98-102. Abstract

11. Hanno PM. Interstitial cystitis-epidemiology, diagnostic criteria, clinical markers. Rev Urol. 2002;4 Suppl 1:S3-8.Full text  Abstract

12. Lewi H. Medical therapy in interstitial cystitis: the Essex experience. Urology. 2001 Jun;57(6 Suppl 1):120. Abstract

13. Close CE, Carr MC, Burns MW, et al. Interstitial cystitis in children. J Urol. 1996 Aug;156(2 Pt 2):860-2. Abstract

14. Erickson DR, Propert KJ. Pregnancy and interstitial cystitis/painful bladder syndrome. Urol Clin North Am. 2007 Feb;34(1):61-9. Abstract

15. Peters KM, Carrico DJ, Diokno AC. Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome. Urology. 2008 Apr;71(4):634-40. Abstract

16. Peters KM, Kalinowski SE, Carrico DJ, et al. Fact or fiction: is abuse prevalent in patients with interstitial cystitis? Results from a community survey and clinic population. J Urol. 2007 Sep;178(3 Pt 1):891-5. Abstract

17. Tirlapur SA, Birch JV, Carberry CL, et al., on behalf of the Royal College of Obstetricians and Gynaecologists. Management of bladder pain syndrome. BJOG. 2017 Jan;124(2):e46-e72.Full text

18. Bullones Rodríguez MÁ, Afari N, Buchwald DS; National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Urological Chronic Pelvic Pain. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2013 Jan;189(1 Suppl):S66-74. Abstract

19. Shorter B, Leser M, Moldwin RM, et al. Effect of comestibles on symptoms of interstitial cystitis. J Urol. 2007 Jul;178(1):145-52. Abstract

20. Killinger KA, Boura JA, Peters KM. Pain in interstitial cystitis/bladder pain syndrome: do characteristics differ in ulcerative and non-ulcerative subtypes? Int Urogynecol J. 2013 Aug;24(8):1295-301. Abstract

21. Hillelsohn JH, Rais-Bahrami S, Friedlander JI, et al. Fulguration for Hunner ulcers: long-term clinical outcomes. J Urol. 2012 Dec;188(6):2238-41. Abstract

22. Erickson DR, Tomaszewski JE, Kunselman AR, et al. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005 Jan;173(1):93-7. Abstract

23. Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005 Sep;66(3):494-9. Abstract

24. Keay S. Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal. 2008 Dec;20(12):2174-9. Abstract

25. Seth JH, Sahai A, Khan MS, et al. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? BJU Int. 2013 Mar;111(3):372-80. Abstract

26. Payne C, Allee T. Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes. Neurourol Urodyn. 2009;28(1):13-7. Abstract

27. Alagiri M, Chottiner S, Ratner V, et al. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology. 1997 May;49(5A Suppl):52-7. Abstract

28. Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, et al. Case-control study of medical comorbidities in women with interstitial cystitis. J Urol. 2008 Jun;179(6):2222-5. Abstract

29. Peters K, Girdler B, Carrico D, et al. Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation. Int Urogynecol J Pelvic Floor Dysfunct. 2008 May;19(5):665-9. Abstract

30. Yamada T, Sakai N, Murayama T, et al. Two cases of interstitial cystitis complicated with migraine [in Japanese]. Hinyokika Kiyo. 1999 Jan;45(1):61-4. Abstract

31. van de Merwe JP. Interstitial cystitis and systemic autoimmune diseases. Nat Clin Pract Urol.2007 Sep;4(9):484-91. Abstract

32. Lee J, Doggweiler-Wiygul R, Kim S, et al. Is interstitial cystitis an allergic disorder? A case of interstitial cystitis treated successfully with anti-IgE. Int J Urol. 2006 May;13(5):631-4. Abstract

33. Kushner L, Moldwin RM. Efficiency of questionnaires used to screen for interstitial cystitis. J Urol. 2006 Aug;176(2):587-92. Abstract

34. Clemens JQ, Brown SO, Kozloff L, et al. Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol. 2006 Mar;175(3 Pt 1):963-6. Abstract

35. Paulson JD, Delgado M. The relationship between interstitial cystitis and endometriosis in patients with chronic pelvic pain. JSLS. 2007 Apr-Jun;11(2):175-81. Abstract

36. Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology. 2009 Jan;73(1):52-7. Abstract

37. American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. December 2014 [internet publication].Full text

38. Cox A, Golda N, Nadeau G, et al. CUA guideline: diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016 May-Jun;10(5-6):E136-55.Full text  Abstract

39. Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynaecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002 Oct;60(4):573-8. Abstract

40. O'Leary MP, Sant GR, Fowler FJ Jr, et al. The interstitial cystitis symptom index and problem index. Urology. 1997 May;49(5A Suppl):58-63. Abstract

41. Propert KJ, Mayer RD, Wang Y, et al. Responsiveness of symptom scales for interstitial cystitis. Urology. 2006 Jan;67(1):55-9. Abstract

42. Geirsson G, Wang YH, Lindstrom S, et al. Traditional acupuncture and electrical stimulation of the posterior tibial nerve: a trial in chronic interstitial cystitis. Scand J Urol Nephrol. 1993;27(1):67-70. Abstract

43. Hanno PM, Landis JR, Matthews-Cook Y, et al; Interstitial Cystitis Database Study Group. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol. 1999 Feb;161(2):553-7. Abstract

44. Nickel JC, Barkin J, Forrest J, et al; Elmiron study group. Randomized, double blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology. 2005 Apr;65(4):654-8. Abstract

45. Nickel JC, Herschorn S, Whitmore KE, et al. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol. 2015 Mar;193(3):857-62.Full text  Abstract

46. Amrute KV, Moldwin RM. Pharmacotherapy of interstitial cystitis in women. Womens Health (Lond Engl).2007 Jan;3(1):63-72.

47. Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology. 1997 May;49(5A Suppl):108-10. Abstract

48. Sant GR, Propert KJ, Hanno PM, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003 Sep;170(3):810-5. Abstract

49. Pranikoff K, Constantino G. The use of amitriptyline in patients with urinary frequency and pain. Urology. 1998 May;51(5A Suppl):179-81. Abstract

50. van Ophoven A, Pokupic S, Heinecke A, et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004 Aug;172(2):533-6. Abstract

51. van Ophoven A, Hertle L. Long term results of amitriptyline treatment for interstitial cystitis. J Urol. 2005 Nov;174(5):1837-40. Abstract

52. Hansen HC. Interstitial cystitis and the potential role of gabapentin. South Med J. 2000 Feb;93(2):238-42. Abstract

53. Lewis SC, Bhattacharya S, Wu O, et al. Gabapentin for the management of chronic pelvic pain in women (GaPP1): a pilot randomised controlled trial. PLoS One. 2016 Apr 12;11(4):e0153037.Full text  Abstract

54. Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol. 2004 Jun;171(6 Pt 1):2138-41. Abstract

55. Forrest JB, Payne CK, Erickson DR. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. J Urol. 2012 Oct;188(4):1186-91. Abstract

56. Faculty of Pain Medicine; British Pain Society; Royal College of Nurses; et al. Core standards for pain management services in the UK. October 2015 [internet publication].Full text

57. Nickel JC, Moldwin R, Lee S, et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009 Apr;103(7):910-8. Abstract

58. Nomiya A, Naruse T, Niimi A, et al. On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis. Int J Urol. 2013 Nov;20(11):1118-22.Full text  Abstract

59. Barua JM, Arance I, Angulo JC, et al. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2016 Aug;27(8):1137-47.Full text  Abstract

60. Smith CP, Radziszewski P, Borkowski A, et al. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology. 2004 Nov;64(5):871-5. Abstract

61. Giannantoni A, Costantini E, Di Stasi SM, et al. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur Urol. 2006 Apr;49(4):704-9.Full text  Abstract

62. Kuo HC, Jiang YH, Tsai YC, et al. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment: a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn. 2016 Jun;35(5):609-14. Abstract

63. Bhide AA, Puccini F, Khullar V, et al. Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature. Int Urogynecol J. 2013 Sep;24(9):1429-34. Abstract

64. Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int. 2004 Apr;93(6):777-9. Abstract

65. Peters K, Killinger K, Boguslawski BM, et al. Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms. Neurourol Urodyn. 2010 Sep;29(7):1267-71. Abstract

66. Fariello JY, Whitmore K. Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction. Int Urogynecol J. 2010 Dec;21(12):1553-8. Abstract

67. van Balken MR, Vandoninck V, Messelink BJ, et al. Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. Eur Urol. 2003 Feb;43(2):158-63. Abstract

68. Lee CL, Kuo HC. Intravesical botulinum toxin A injections do not benefit patients with ulcer type interstitial cystitis. Pain Physician. 2013 Mar-Apr;16(2):109-16. Abstract

69. Peters KM, Jaeger C, Killinger KA, et al. Cystectomy for ulcerative interstitial cystitis: sequelae and patients' perceptions of improvement. Urology. 2013 Oct;82(4):829-33. Abstract

70. Yang TX, Luo DY, Li H, et al. Is urethrectomy necessary during cystectomy in patients with interstitial cystitis or bladder pain syndrome? Urology. 2016 Nov;97:73-9. Abstract

71. Nickel JC, Egerdie B, Davis E, et al. A phase II study of the efficacy and safety of the novel oral SHIP1 activator AQX-1125 in subjects with moderate to severe interstitial cystitis/bladder pain syndrome. J Urol. 2016 Sep;196(3):747-54. Abstract

Use of this content is subject to our disclaimer